Veeva stock gains as Biogen selects Vault CRM globally By Investing.com
Veeva stock gains as Biogen selects Vault CRM globally By Investing.com Investing.com Canada
Covered in this story
What has happened since
- Biogen is up 15.0% since this was published, 58 days ago.
- Veeva Systems is up 30.7% since this was published, 58 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Biogen
- BMO Capital Markets: $229 → $220 by Oct 2027 · Market Perform via Investing.com
- Wolfe Research: $216 → $300 by Sep 2027 · Outperform via Yahoo Finance
- H.C. Wainwright: $203 → $251 by Jul 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $BIIB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Biogen →Summary aggregated from Investing.com Canada's public RSS feed. The full reporting belongs to Investing.com Canada — please read it on their site.